Data Availability
All data relevant for the interpretation of our findings is provided in the main manuscript or the supplemental information. Dataset 1: Panel sequencing data, cfDNA and matched gDNA, from the ProBio trial (ClinicalTrials.gov identifier: NCT03903835, www.probiotrial.org). Any data providing information on individual outcomes or genotypes is considered to be a personal registry by the Swedish law (Personal Data Act), thereby prohibiting the submission of the sequencing files to a public repository. Access to the sequencing data data requires approval from the Swedish Ethical Review Authority and an agreement with the data protection- and legal unit at Karolinska Institutet. Dataset 2: Panel sequencing data of cfDNA from the MAGNITUDE trial (ClinicalTrials.gov identifier: NCT03748641). The data sharing policy is described in the publication, "Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer", pmid 36952634. Dataset 3: Panel sequencing data and low-pass whole genome sequencing from a Danish retrospective cohort. See publication "Prognostic Value of Low-Pass Whole Genome Sequencing of Circulating Tumor DNA in Metastatic Castration-Resistant Prostate Cancer", pmid 36762756, for data access information.
